Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196
Clinical trial NCT04479631 · COMPLETED
Trial details
- NCT number
- NCT04479631
- Sponsor
- Brii Biosciences Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-12
- Primary completion
- 2021-01-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.